Cite
Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art.
MLA
Lambuk, Lidawani, et al. “Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art.” Frontiers in Pharmacology, vol. 13, May 2022, pp. 1–17. EBSCOhost, https://doi.org/10.3389/fphar.2022.875662.
APA
Lambuk, L., Mohd Lazaldin, M. A., Ahmad, S., Iezhitsa, I., Agarwal, R., Uskoković, V., & Mohamud, R. (2022). Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art. Frontiers in Pharmacology, 13, 1–17. https://doi.org/10.3389/fphar.2022.875662
Chicago
Lambuk, Lidawani, Mohd Aizuddin Mohd Lazaldin, Suhana Ahmad, Igor Iezhitsa, Renu Agarwal, Vuk Uskoković, and Rohimah Mohamud. 2022. “Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art.” Frontiers in Pharmacology 13 (May): 1–17. doi:10.3389/fphar.2022.875662.